Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for expression wrinkles in the upper face
NCT00986570Phase 3Completed
- Sponsor
- Biolab Farmacêutica
- Start
- Sep 2009
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in rhytides, sponsored by Biolab Farmacêutica. Started Sep 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on NCT00986570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986570.